In this study, we aimed to confirm the association of FBLN2 with myoepithelial phenotype in mammary epithelium and further investigate the expression of FBLN2 in human breast cancer subtypes in relevance to patients’ outcomes. The gene discussed is FBLN2; the disease is breast cancer.